Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity

GlaxoSmithKline (GSK)

Status and phase: Completed; Phase 3

Conditions: Dentine Hypersensitivity

Treatments: Drug: Stannous Fluoride; Drug: Sodium Monofluorophosphate

Study type: Interventional

Funder types: Industry

Identifiers

NCT01592851

RH01324

Details and patient eligibility

About

A study to compare the efficacy of a test dentifrice against a control dentifrice in reducing dentinal hypersensitivity over a two week treatment period.

Enrollment: 113 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

• Subjects who suffer from tooth sensitivity.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

113 participants in 2 patient groups

Arm 1

Experimental group

Description:

Dentifrice containing stannous fluoride

Treatment:

Drug: Stannous Fluoride

Arm 2

Active Comparator group

Description:

Marketed dentifrice containing Sodium Monofluorophosphate

Treatment:

Drug: Sodium Monofluorophosphate